The Effect of Discontinuing Denosumab in Patients With Rheumatoid Arthritis Treated With Glucocorticoids

OBJECTIVE: To evaluate changes in bone turnover and bone mineral density (BMD) in patients with rheumatoid arthritis (RA) receiving glucocorticoids, after discontinuation of denosumab for 12 months. METHODS: We conducted a randomized, double‐blind, placebo‐controlled, phase II study of RA patients....

Descripción completa

Detalles Bibliográficos
Autores principales: Saag, Kenneth G., McDermott, Michele T., Adachi, Jonathan, Lems, Willem, Lane, Nancy E., Geusens, Piet, Stad, Robert Kees, Chen, Li, Huang, Shuang, Dore, Robin, Cohen, Stanley
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Periodicals, Inc. 2022
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305881/
https://www.ncbi.nlm.nih.gov/pubmed/34535967
http://dx.doi.org/10.1002/art.41981

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305881/
https://www.ncbi.nlm.nih.gov/pubmed/34535967
http://dx.doi.org/10.1002/art.41981

Ejemplares similares